Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.

@article{Smith2012TripleAT,
  title={Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.},
  author={Jan Gustav Smith and Mattias Wieloch and Sasha Koul and Oscar {\"O}. Braun and Jonathan Lumsden and Emil Rydell and Jenny Ohman and Fredrik Scherst{\'e}n and Peter J. Svensson and Jesper van der Pals},
  journal={EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology},
  year={2012},
  volume={8 6},
  pages={672-8}
}
AIMS The aim of this study was to evaluate the prevalence of triple antithrombotic therapy (TT) (warfarin, aspirin and clopidogrel) in patients following an acute coronary syndrome (ACS), the bleeding risk compared to double antiplatelet therapy (DAPT) (aspirin and clopidogrel) and evaluate the accuracy of the HAS-BLED risk score in predicting serious… CONTINUE READING